Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Olon SpA Acquires Part of Ricerca Biosciences | Contract Pharma

What are you searching for?

Sign in
Breaking News

Olon SpA Acquires Part of Ricerca Biosciences

Strengthens service offering of global CDMO and generics provider for research and manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Olon S.p.A. (www.olonspa.com), an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has acquired the chemical division of the contract research organization (CRO) and CDMO Ricerca Biosciences (www.ricerca.com) based in Concord, OH. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry, and will benefit the Ricerca Biosciences customer base by providing large scale manufacturing capabilities in Europe.

“By acquiring a research and manufacturing base in the U.S., Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop new generic products for the U.S. market,” said Paolo Tubertini, chief executive officer, Olon. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics